Progen Co., Ltd. (XKON:296160)
South Korea · Delayed Price · Currency is KRW 6,160.00
-150.00 (-2.38%)
At close: Mar 12, 2026
Progen Market Cap
Progen has a market cap or net worth of 94.71 billion as of March 12, 2026. Its market cap has increased by 33.53% in one year.
Market Cap
94.71B
Enterprise Value
n/a
Revenue
450.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
6,160.00
Market Cap Chart
Since November 15, 2023, Progen's market cap has increased from 46.33B to 94.71B, an increase of 104.45%. That is a compound annual growth rate of 36.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 94.71B | -18.30% |
| Dec 30, 2025 | 115.93B | 28.30% |
| Dec 30, 2024 | 90.36B | 9.39% |
| Dec 28, 2023 | 82.60B | 78.30% |
| Nov 15, 2023 | 46.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IMGT Co.,Ltd. | 122.47B |
| BIO-FD&C | 122.17B |
| CORESTEMCHEMON | 117.55B |
| ViGenCell | 117.46B |
| NovMetaPharma | 113.90B |
| Quratis | 99.21B |
| TegoScience | 96.08B |
| CTCBIO | 95.75B |